Iridex® MicropulseTM Technology Explained using Computer Animation

Iridex Micropulse Technology

Carleton Ltd, the exclusive distributor of Iridex lasers and delivery devices in the UK, has introduced a new educational animation video that helps to explain the benefits of Iridex Micropulse technology. This new video clip, produced by Iridex as part of their 20th anniversary celebration, is available in both a 5 minute version for medical professionals and a 2 minute clip for patients.

MicroPulse is a laser delivery modality that adds finer control of photothermal effects in laser photocoagulation. Using MicroPulse for laser trabeculoplasty (MLT) offers a tissue-sparing technology for the reduction of intraocular pressure. Unlike conventional laser trabeculoplasty procedures, there is no destructive, coagulative damage to the meshwork.

Used in the retina, MicroPulse settings extend the aspects of tissue-sparing applications to treatments otherwise performed with conventional photocoagulation. DME, CSR, and even PRP are areas where MicroPulse technology can be utilized.

In conventional photocoagulation, the temperature rise for an intended intraoperative endpoint is controlled by adjusting the power and the exposure duration of the continuous-wave (CW) laser emission. With MicroPulse, the steady CW emission is “chopped” into a train of short laser pulses, whose “width” (“ON” time) and “interval” (“OFF” time) are adjustable by the surgeon. A shorter MicroPulse “width” limits the time for the laser-induced heat to spread to adjacent tissues, thus providing fine control of energy delivered. A longer MicroPulse “interval” between pulses allows cooling to take place before the next pulse is delivered.

To order the video animation on CD or for more information regarding Iridex laser products and applications, please contact Carleton Ltd on (01494) 775811.
 

 
 

Latest News

Subscribe via RSS Syndicate content

dio-banner.jpg

Events

  • 27 January, 2012 - 30 June, 2012

    Ophthalmic Laser Study Day 2012

    Carleton Optical in association with IRIDEX are pleased to announce plans for an ophthalmic laser awareness study day.

    Subjects to be covered will include innovative treatments for diabetic retinopathy, an update on transcleral cyclophotocoagulation and a review of the IQ 577nm Yellow Laser. Whilst timings are yet to be confirmed, it will be a London venue probably in the second half of July 2012.